Since the Human Genome Project first produced the genetic instructions for a human being by sequencing DNA 22 years ago, ...

In April 2025, the US Food and Drug Administration (FDA) published a roadmap for leveraging new approach methodologies (NAMs), including in silico approaches such as artificial intelligence (AI), to ...

Traditionally, drug discovery relied heavily on trial and error, with long timelines and high costs. The introduction of ...

The PocketMBA program embodies UD PCS’ commitment to equipping professionals with the skills necessary to excel in dynamic ...

In an effort to foster progress in cancer research, the National Institute of Standards and Technology (NIST) is releasing detailed and comprehensive data about the entire genetic content of a ...

The FDA’s Orphan Drug program is designed to encourage and support the development of treatments for rare diseases or conditions. The designation’s benefits include financial incentives such as tax ...

GeneDx leverages a vast rare disease database and advanced genomic testing, offering superior insights. Read why I am bullish about WGS stock.

Slipstream has co-authored a landmark study on Hereditary Hemorrhagic Telangiectasia (HHT), offering the most comprehensive ...

A large-scale bibliometric analysis maps global research on hydrogels as next-generation drug delivery systems for cancer ...